Kevin Sun Biography and Net Worth

CFO of DermTech

Kevin Sun brings nearly two decades of corporate finance experience, including debt and equity financings, acquisitions, commercial product launches and infrastructure scaling and expansion projects mostly in the medical device and diagnostic industries. Previously, Mr. Sun served in various executive and management roles for DexCom, Inc., a NASDAQ-listed medical device company, including most recently as Vice President, Corporate Controller and Treasury, Interim Chief Financial Officer, and Vice President, Finance, and had key roles during a phase of significant growth and expansion. Prior to DexCom, Mr. Sun held various roles of increasing responsibility at Biosite Incorporated, a NASDAQ-listed leader in rapid point of care diagnostics. Mr. Sun holds a Bachelor of Science in Business with a dual major in Accounting and Finance, a minor in Psychology, a master’s degree in Strategic Management and an MBA from the Kelley School of Business at Indiana University.

What is Kevin M. Sun's net worth?: The estimated net worth of Kevin M. Sun is at least $0.00 as of December 11th, 2023. Mr. Sun owns 277,499 shares of DermTech stock worth more than $0 as of April 2nd. This net worth approximation does not reflect any other investments that Mr. Sun may own. Additionally, Mr. Sun receives an annual salary of $600,350.00 as CFO at DermTech. Learn More about Kevin M. Sun's net worth.
How old is Kevin M. Sun?: Mr. Sun is currently 46 years old. There are 4 older executives and no younger executives at DermTech. The oldest executive at DermTech is Dr. Burkhard Jansen M.D., Chief Medical Affairs Officer, who is 58 years old. Learn More on Kevin M. Sun's age.
What is Kevin M. Sun's salary?: As the CFO of DermTech, Inc., Mr. Sun earns $600,350.00 per year. The highest earning executive at DermTech is Mr. Bret Christensen, President, CEO & Director, who commands a salary of $973,970.00 per year. Learn More on Kevin M. Sun's salary.
How do I contact Kevin M. Sun?: The corporate mailing address for Mr. Sun and other DermTech executives is 11099 N. Torrey Pines Road Suite 100, La Jolla CA, 92037. DermTech can also be reached via phone at (858) 450-4222 and via email at investorrelations@dermtech.com. Learn More on Kevin M. Sun's contact information.
Has Kevin M. Sun been buying or selling shares of DermTech?: Kevin M. Sun has not been actively trading shares of DermTech over the course of the past ninety days. Most recently, Kevin M. Sun sold 447 shares of the business's stock in a transaction on Monday, December 11th. The shares were sold at an average price of $1.45, for a transaction totalling $648.15. Following the completion of the sale, the chief financial officer now directly owns 277,499 shares of the company's stock, valued at $402,373.55. Learn More on Kevin M. Sun's trading history.
Who are DermTech's active insiders?: DermTech's insider roster includes John Dobak (CEO), Claudia Ibarra (COO), Scott Pancoast (Director), Enrico Picozza (Director), Kevin Sun (CFO), and Todd Wood (Insider). Learn More on DermTech's active insiders.

Kevin M. Sun Insider Trading History at DermTech

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/11/2023	Sell	447	$1.45	$648.15	277,499
12/7/2023	Sell	4,979	$1.53	$7,617.87	277,946
9/11/2023	Sell	436	$1.89	$824.04	282,925
9/8/2023	Sell	9,180	$1.93	$17,717.40	283,361
6/12/2023	Sell	437	$2.85	$1,245.45	290,041
6/7/2023	Sell	4,988	$2.53	$12,619.64	293,306
3/13/2023	Sell	514	$3.26	$1,675.64	298,294
3/7/2023	Sell	8,687	$4.06	$35,269.22	216,714
9/6/2022	Sell	178	$5.43	$966.54	222,901
3/11/2022	Sell	435	$14.55	$6,329.25
3/7/2022	Sell	726	$13.03	$9,459.78
9/13/2021	Sell	622	$36.19	$22,510.18	149,939
9/8/2021	Sell	4,276	$36.19	$154,748.44
6/11/2021	Sell	1,933	$41.08	$79,407.64	154,478
6/8/2021	Sell	2,870	$43.43	$124,644.10	156,411
3/8/2021	Sell	2,886	$50.04	$144,415.44

Kevin M. Sun Buying and Selling Activity at DermTech

DermTech Company Overview

DermTech, Inc., a molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. In addition, it provides research services and technology platform on a contract basis to pharmaceutical companies which use the technology for clinical trials. Further, the company develops gene expression assays for the psoriasis, atopic dermatitis, and aging of the skin to pharmaceutical companies to develop drug products in dermatology; and develop custom gene assays to support the pharmaceutical partners. It sells its products through pathology and oncology practitioners. DermTech, Inc. is headquartered in San Diego, California.

Today's Range

Now: N/A

50 Day Range

MA: $0.19

$0.05

$0.42

2 Week Range

Now: N/A

Volume

3,662,300 shs

Average Volume

1,065,175 shs

Market Capitalization

$3.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.48

Kevin Sun Biography and Net Worth

What is Kevin M. Sun's net worth?

How old is Kevin M. Sun?

What is Kevin M. Sun's salary?

How do I contact Kevin M. Sun?

Has Kevin M. Sun been buying or selling shares of DermTech?

Who are DermTech's active insiders?